ROPES & GRAY, LLP for MEDICAL INFORMATION WORKING GROUP
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products.
Foreign entity interest: Allergan, Plc, a pharmaceutical company, is a member of the Medical Information Working Group (MIWG), which seeks clarity in the FDA regulatory scheme regarding the dissemination of truthful non-misleading information about prescription drugs, biological products and medical devices, and to improve the federal regulatory framework and enforcement climate affecting manufacturer dissemination of information regarding those products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLIE COMBS | — |
| JOAN MCPHEE New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROCHE HOLDING AG IS THE PARENT COMPANY OF MIWG MEMBER, GENENTECH, INC. | Switzerland | Switzerland | 7.7% | $12,300 |
| ALLERGAN, PLC IS A MEMBER OF MIWG | Ireland | Ireland | 7.7% | $12,300 |
| NOVARTIS AG IS THE PARENT COMPANY OF MIWG MEMBER, NOVARTIS PHARMACEUTICALS CORP. | Switzerland | Switzerland | 7.7% | $12,300 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.